We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CRM icon
26
Salesforce
CRM
$189B
$53.3M 0.54%
207,261
+9,044
+5% +$2.42M
2020 Q2
16 quarters
JNJ icon
27
Johnson & Johnson
JNJ
$630B
$52.9M 0.54%
361,982
-7,077
-2% -$1.05M
2020 Q2
16 quarters
ORCL icon
28
Oracle
ORCL
$429B
$52M 0.53%
368,512
+87,089
+31% +$10.8M
2020 Q2
16 quarters
PEP icon
29
PepsiCo
PEP
$172B
$48.4M 0.5%
293,701
+11,046
+4% +$1.91M
2020 Q2
16 quarters
KO icon
30
Coca-Cola
KO
$379B
$48.2M 0.49%
756,868
-25,080
-3% -$1.55M
2020 Q2
16 quarters
AMAT icon
31
Applied Materials
AMAT
$402B
$46.8M 0.48%
198,202
+5,637
+3% +$1.21M
2020 Q2
16 quarters
INTU icon
32
Intuit
INTU
$80.9B
$41.1M 0.42%
62,551
+653
+1% +$405K
2020 Q2
16 quarters
WMT icon
33
Walmart Inc
WMT
$883B
$40M 0.41%
590,872
-1,509
-0.3% -$95K
2020 Q2
16 quarters
BAC icon
34
Bank of America
BAC
$380B
$38.5M 0.39%
969,032
-19,847
-2% -$761K
2020 Q2
16 quarters
NOW icon
35
ServiceNow
NOW
$146B
$38.3M 0.39%
243,350
+2,775
+1% +$407K
2020 Q2
16 quarters
AMGN icon
36
Amgen
AMGN
$224B
$37.4M 0.38%
119,858
+5,175
+5% +$1.52M
2020 Q2
16 quarters
CVX icon
37
Chevron
CVX
$416B
$36.5M 0.37%
233,540
-6,471
-3% -$1.03M
2020 Q2
16 quarters
ISRG icon
38
Intuitive Surgical
ISRG
$150B
$36.1M 0.37%
81,199
-2,928
-3% -$1.17M
2020 Q2
16 quarters
LRCX icon
39
Lam Research
LRCX
$399B
$34.2M 0.35%
320,840
+4,540
+1% +$435K
2020 Q2
16 quarters
UBER icon
40
Uber
UBER
$146B
$33.4M 0.34%
459,163
+8,520
+2% +$592K
2020 Q2
16 quarters
WFC icon
41
Wells Fargo
WFC
$253B
$32.9M 0.34%
553,758
-23,918
-4% -$1.41M
2020 Q2
16 quarters
BKNG icon
42
Booking.com
BKNG
$120B
$31.4M 0.32%
198,375
-5,125
-3% -$759K
2020 Q2
16 quarters
TMO icon
43
Thermo Fisher Scientific
TMO
$243B
$30.8M 0.31%
55,708
-23,200
-29% -$13.3M
2020 Q2
16 quarters
LIN icon
44
Linde
LIN
$223B
$29.5M 0.3%
67,140
-4,445
-6% -$1.96M
2020 Q2
16 quarters
UNP icon
45
Union Pacific
UNP
$165B
$29.1M 0.3%
128,603
+20,035
+18% +$4.7M
2020 Q2
16 quarters
MCD icon
46
McDonald's
MCD
$166B
$28.7M 0.29%
112,677
-25,602
-19% -$6.79M
2020 Q2
16 quarters
CSCO icon
47
Cisco
CSCO
$467B
$27.5M 0.28%
579,134
-13,534
-2% -$643K
2020 Q2
16 quarters
ACN icon
48
Accenture
ACN
$128B
$26.8M 0.27%
88,492
-59,238
-40% -$18.1M
2020 Q2
16 quarters
GE icon
49
GE Aerospace
GE
$320B
$26.7M 0.27%
168,182
-33,673
-17% -$5.38M
2021 Q3
11 quarters
KLAC icon
50
KLA
KLAC
$255B
$26.5M 0.27%
321,830
+350
+0.1% +$25.9K
2020 Q2
16 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.